
Plazy LS 75mg/40mg Capsule SR
Marketer
Amista Labs Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Pantoprazole (40mg)
Overview Plazy LS 75mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) symptoms, including heartburn, stomach upset, and irritation, are addressed by the sustained-release capsule, Plazy LS 75mg/40mg SR. This medication neutralizes stomach acid and facilitates gas expulsion, easing discomfort. Dosage and duration for Plazy LS 75mg/40mg SR are determined by your physician and should be taken on an empty stomach. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions may occur. Common, typically transient, side effects include abdominal pain, vomiting, diarrhea, headache, fever, nausea, rash, and flatulence. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or activities requiring alertness until its effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Lifestyle changes such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate can improve outcomes. Prior to commencing treatment, disclose any kidney conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Plazy LS 75mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Plazy LS 75mg/40mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Plazy LS 75mg/40mg Sustained-Release Capsules on an empty stomach.
Common Side effects of Plazy LS 75mg/40mg Capsule SR:
- Stomach pain
- Vomiting
- Diarrhea
- Headache
- Nausea
- Flatulence
- Fundic gland polyps
- Fever
- Skin rash
- Dizziness
How to use Plazy LS 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Plazy LS 75mg/40mg Capsule SR whole; do not crush, chew, or break it. Administer on an empty stomach.
How Plazy LS 75mg/40mg Capsule SR works:
Each Plazy LS 75mg/40mg sustained-release capsule contains levosulpiride and pantoprazole, working in tandem.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Plazy LS 75mg/40mg extended-release capsules and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Use of Plazy LS 75mg/40mg sustained-release capsules is contraindicated in pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
The extended-release Plazy LS 75mg/40mg capsule is contraindicated during lactation. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Plazy LS 75mg/40mg Capsule SR, which can induce drowsiness, dizziness, or dyskinesia. Consequently, individuals using this medication should refrain from driving and other activities demanding alertness.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Plazy LS 75mg/40mg sustained-release capsules. Dosage modification of Plazy LS 75mg/40mg sustained-release capsules may be necessary. Medical advice is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Plazy LS 75mg/40mg sustained-release capsules. Dosage modification of Plazy LS 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Plazy LS 75mg/40mg Capsule SR :
Should you forget a Plazy LS 75mg/40mg Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Plazy LS 75mg/40mg Capsule SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Gastrointestinal system |
